RISE-MX, a real-world study of patients with moderate/severe inflammatory bowel disease returning for hospital follow-up in Mexico: baseline demographics and clinical characteristics, treatment and disease status.

ABSTRACT:

Background

Inflammatory bowel disease (IBD) is characterized by periods of remission and relapses, and treatment is based on phenotype, risk factors, and disease severity. Treatments include 5-aminosalicylates (5-ASA), thiopurines, methotrexate, calcineurin inhibitors, corticosteroids (CS), biological therapy (BxT), and, more recently, small molecules.

Objective

To determine the baseline demographics and clinical characteristics, treatment patterns, and disease status of patients in Mexico with a history of moderate/severe IBD returning for hospital follow-up (Index Day).

Design

This was a non-interventional, cross-sectional study.

Methods

Socio-demographics, clinical characteristics, and prescribed treatments were collected from a retrospective review (3 years

SUBMITTER: Martinez-Vazquez MA 

PROVIDER: S-EPMC11833814 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature